STE vs. BDX, EW, IDXX, RMD, DXCM, PODD, BAX, HOLX, MASI, and GMED
Should you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), and Globus Medical (GMED). These companies are all part of the "health care equipment" industry.
STERIS vs. Its Competitors
Becton, Dickinson and Company (NYSE:BDX) and STERIS (NYSE:STE) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.
In the previous week, Becton, Dickinson and Company had 21 more articles in the media than STERIS. MarketBeat recorded 32 mentions for Becton, Dickinson and Company and 11 mentions for STERIS. STERIS's average media sentiment score of 1.23 beat Becton, Dickinson and Company's score of 0.89 indicating that STERIS is being referred to more favorably in the news media.
87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 94.7% of STERIS shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by company insiders. Comparatively, 1.1% of STERIS shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Becton, Dickinson and Company currently has a consensus price target of $219.22, indicating a potential upside of 23.58%. STERIS has a consensus price target of $263.83, indicating a potential upside of 9.18%. Given Becton, Dickinson and Company's higher possible upside, research analysts clearly believe Becton, Dickinson and Company is more favorable than STERIS.
STERIS has a net margin of 11.26% compared to Becton, Dickinson and Company's net margin of 7.28%. Becton, Dickinson and Company's return on equity of 15.99% beat STERIS's return on equity.
Becton, Dickinson and Company has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500. Comparatively, STERIS has a beta of 0.92, suggesting that its share price is 8% less volatile than the S&P 500.
Becton, Dickinson and Company has higher revenue and earnings than STERIS. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.
Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.3%. STERIS pays an annual dividend of $2.28 per share and has a dividend yield of 0.9%. Becton, Dickinson and Company pays out 79.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. STERIS pays out 36.8% of its earnings in the form of a dividend. Becton, Dickinson and Company has increased its dividend for 53 consecutive years and STERIS has increased its dividend for 20 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Summary
STERIS beats Becton, Dickinson and Company on 12 of the 19 factors compared between the two stocks.
Get STERIS News Delivered to You Automatically
Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding STE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NYSE:STE) was last updated on 7/2/2025 by MarketBeat.com Staff
